Evidence for tumor-host cooperation in regulating MMP-2 expression in human colon cancer

被引:31
作者
Ornstein, DL
MacNab, J
Cohn, KH
机构
[1] VA Med & Reg Off Ctr, White River Junction, VT 05009 USA
[2] Dartmouth Coll, Sch Med, Dept Med & Surg, Hanover, NH 03755 USA
关键词
colon cancer; fibroblast; metalloproteinase; metastasis;
D O I
10.1023/A:1006562818088
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Matrix metalloproteinase 2 (MMP-2) facilitates tumor growth and metastasis in colon cancer. Although tumor cells may produce MMP-2, stromal cells, such as macrophages and fibroblasts, contribute significantly to MMP-2 synthesis in human tumors. We characterized four human colon cancer cell lines with differing biological behavior for MMP-2 expression. While the parent tumors from which the cell lines were derived all expressed MMP-2 mRNA, MMP-2 transcripts were detected in only one cell line, TF-17C, which is nontumorigenic in a nude mouse tumor model. TF-43C, which is tumorigenic and metastatic in the same tumor model, did not produce MMP-2, yet the tumors which arose from it after injection into nude mice did contain MMP-2 mRNA, suggesting a contribution from stromal cells. Co-culturing TF-43C with fibroblasts resulted in an increase in MMP-2 protein, whereas co-culturing with the nontumorigenic cell line TF-13Cm did not alter constitutive fibroblast MMP-2 secretion. Conditioned medium from TF-43C cells also stimulated fibroblast MMP-2 production. These data suggest that a soluble factor from TF-43C cells can stimulate fibroblast MMP-2 production and support the hypothesis that colon cancer cell interactions with stromal fibroblasts may be important determinants of tumor behavior in vivo.
引用
收藏
页码:205 / 212
页数:8
相关论文
共 52 条
  • [1] Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor
    An, ZL
    Wang, XE
    Willmott, N
    Chander, SK
    Tickle, S
    Docherty, AJP
    Mountain, A
    Millican, AT
    Morphy, R
    Porter, JR
    Epemolu, RO
    Kubota, T
    Moossa, AR
    Hoffman, RM
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 1997, 15 (02) : 184 - 195
  • [2] BARSKY SH, 1983, LAB INVEST, V49, P140
  • [3] PROTEOLYTIC REMODELING OF EXTRACELLULAR-MATRIX
    BIRKEDALHANSEN, H
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1995, 7 (05) : 728 - 735
  • [4] Changing views of the role of matrix metalloproteinases in metastasis
    Chambers, AF
    Matrisian, LM
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (17) : 1260 - 1270
  • [5] The differential regulation and secretion of proteinases from fetal and neonatal fibroblasts by growth factors
    Cullen, B
    Silcock, D
    Brown, LJ
    Gosiewska, A
    Geesin, JC
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (01) : 241 - 250
  • [6] DANEKER GW, 1987, ARCH SURG-CHICAGO, V122, P1470
  • [7] Matrix metalloproteinase inhibitors: Present achievements and future prospects
    Denis, LJ
    Verweij, J
    [J]. INVESTIGATIONAL NEW DRUGS, 1997, 15 (03) : 175 - 185
  • [8] EMMERTBUCK MR, 1994, AM J PATHOL, V145, P1285
  • [9] FARRELL TM, 1998, IN PRESS GASTROENTER
  • [10] TUMOR BASEMENT-MEMBRANE LAMININ IN ADENOCARCINOMA OF RECTUM - AN IMMUNOHISTOCHEMICAL STUDY OF BIOLOGICAL AND CLINICAL-SIGNIFICANCE
    FORSTER, SJ
    TALBOT, IC
    CLAYTON, DG
    CRITCHLEY, DR
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1986, 37 (06) : 813 - 817